Moreover, Adding anti-PD1 antibody into our NK cell expansion system significantly improved NK cell cytotoxicity toward myeloma cells and NK cell transfusion-associated treatment efficacy in terms of suppression of tumor growth and a prolonged survival of myeloma mice. The gene discussed is PDCD1; the disease is plasma cell myeloma.